Discover the innovative solution to weight management with Mounjaro, now available through our Patient Group Direction (PGD) service. Mounjaro, a cutting-edge medication, is designed to support individuals on their weight loss journey, offering a new pathway to achieving and maintaining a healthy weight.
### Key Features of Mounjaro for Weight Loss:
- **Effective Weight Management:** Mounjaro works by regulating appetite and food intake, helping you to feel fuller for longer and reducing the urge to overeat.
- **Convenient Administration:** Administered through injection, Mounjaro is a practical option for those seeking an alternative to oral weight loss medications.
- **Tailored to Your Needs:** Available under our PGD service, Mounjaro is prescribed after a thorough assessment by our qualified healthcare professionals, ensuring it's suitable for your specific health profile.
### Why Choose Our PGD Service for Mounjaro?
Our PGD service allows for the direct supply of Mounjaro to eligible patients without the need for a traditional prescription. This service is guided by strict protocols to ensure patient safety and efficacy of treatment.
### Who Can Benefit?
Mounjaro is recommended for adults struggling with weight management, particularly those who have not achieved their desired weight loss through diet and exercise alone. It is an excellent option for individuals looking for a scientifically backed treatment to complement their weight loss efforts.
### Getting Started:
To access Mounjaro through our PGD service, start by completing our online consultation. Our team of healthcare professionals will review your information to determine if Mounjaro is the right choice for you.
###What are the service inclusion criteria?*
Mounjaro KwickPen is suitable for a specific group of individuals who meet the following criteria:
1. **Age Range:** People aged between 18 and 84 years.
2. **BMI Threshold:** People with an initial Body Mass Index (BMI) of 30 kg/m² or greater qualify for Mounjaro.
3. **Failed Previous Weight Management Attempts:** The pen is intended for people for whom prior attempts at weight reduction, including supervised diet, behaviour modification, and increased physical activity, have not resulted in a practical and sustainable reduction in weight.
4. **Weight-Related Comorbidities:** People with an initial BMI of 27 kg/m² or greater are also eligible if they have at least one weight-related comorbidity. These comorbidities may include, but are not limited to:
- Hypertension
- Dyslipidaemia
- Obstructive sleep apnoea
- Cardiovascular disease
- Type 2 diabetes mellitus
*What will happen once I have answered the questions in the form?*
A pharmacist trained to provide this private service will assess the form and call you to discuss the answers you provided with you.
**Please note**
**You should select the strength of Mounjaro recommended in your personal treatment plan, starting with the 2.5 mg.** If you have doubts about this, please ask our pharmacist before proceeding with your order on pharmacy@medino.com.
We may need to identify the intended user with an identity check. More information about this will be provided during the consultation.
***
Patient information leaflet
About medino:
The pharmacy in your phone! Fast delivery, good value and free shipping over £20.
Visit Product PageEmail:
info@medino.com
Location:
Unit 5, Ouzel Industrial Estate,
Union Park, Grovebury Road,
Leighton Buzzard
United Kingdom
LU74UX
